We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

84 hedge funds and large institutions have $527M invested in Avadel Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 20

21% more capital invested

Capital invested by funds: $435M → $527M (+$91.6M)

5% more call options, than puts

Call options by funds: $1.74M | Put options by funds: $1.65M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

11% less funds holding

Funds holding: 94 → 84 (-10)

36% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 28

Holders
84
Holders Change
-10
Holders Change %
-10.64%
% of All Funds
2.24%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
18
Increased
33
Reduced
20
Closed
28
Calls
$1.74M
Puts
$1.65M
Net Calls
+$82K
Net Calls Change
+$707K

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$46.7M
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$18.2M
3
Deutsche Bank
Deutsche Bank
Germany
+$14.9M
4
SCM
Sarissa Capital Management
Connecticut
+$13.7M
5
Millennium Management
Millennium Management
New York
+$11.5M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$18.6M
2
CM
Castleark Management
Illinois
-$10.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.24M
4
BC
Broadfin Capital
New York
-$6.78M
5
MACM
March Altus Capital Management
Connecticut
-$6.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
26
Avoro Capital Advisors
New York
$3.88M +$14.1K +900 +0.4%
CS
27
Candriam SCA
Luxembourg
$3.74M +$251K +16,000 +8%
GTC
28
Ghost Tree Capital
New York
$3.6M -$1.96M -125,000 -38%
TI
29
Turner Investments
Pennsylvania
$2.85M -$956K -61,044 -28%
WMSA
30
Weiss Multi-Strategy Advisers
New York
$2.33M -$2.2M -140,200 -52%
CCI
31
Columbus Circle Investors
$2.3M +$243K +15,513 +14%
IHM
32
Iguana Healthcare Management
New York
$2.25M +$1.96M +125,000 New
SCM
33
Suffolk Capital Management
New York
$2.24M +$1.95M +124,753 New
DCM
34
Driehaus Capital Management
Illinois
$2.12M -$1.49M -95,363 -45%
WSA
35
Wall Street Associates
California
$2M -$29.7K -1,900 -2%
Morgan Stanley
36
Morgan Stanley
New York
$1.91M -$4.84M -308,826 -74%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.9M – – –
Comerica Bank
38
Comerica Bank
Texas
$1.88M -$915K -58,465 -36%
FPC
39
Falcon Point Capital
California
$1.86M +$1.62M +103,644 New
CPIM
40
Columbia Partners Investment Management
Virginia
$1.64M +$1.43M +91,278 New
AA
41
AQR Arbitrage
Connecticut
$1.5M +$1.3M +83,300 New
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$1.3M -$9.24M -589,864 -89%
Janney Montgomery Scott
43
Janney Montgomery Scott
Pennsylvania
$1.29M +$137K +8,745 +14%
TI
44
Trexquant Investment
Connecticut
$940K +$503K +32,100 +159%
TD Asset Management
45
TD Asset Management
Ontario, Canada
$939K +$67.3K +4,300 +9%
OPPM
46
Opus Point Partners Management
New York
$751K – – –
OAM
47
Oxford Asset Management
United Kingdom
$709K +$617K +39,413 New
EVM
48
Eaton Vance Management
Massachusetts
$624K – – –
UBS Group
49
UBS Group
Switzerland
$614K -$157K -10,022 -23%
ProShare Advisors
50
ProShare Advisors
Maryland
$565K +$99.1K +6,330 +25%
1
2
3 4 5

AVDL Hedge Fund Activity: Q1 2015 in Review

84 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2015, worth a combined $527M — up 21% from $435M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of AVDL and 18 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 33 added.

The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $46.7M. The largest seller was Deerfield Management, cutting an estimated $18.6M.

  • 84 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2015, down from 94 in Q4 2014.
  • Funds reported $527M of Avadel Pharmaceuticals stock for Q1 2015, up 21% quarter-over-quarter.
  • 18 funds opened new Avadel Pharmaceuticals positions in Q1 2015 and 28 closed out, a net change of -10 holders.
  • The largest Avadel Pharmaceuticals buyer in Q1 2015 was Janus Henderson Investors US, an estimated $46.7M added.
  • The largest Avadel Pharmaceuticals seller in Q1 2015 was Deerfield Management, an estimated $18.6M sold.

Based on aggregated 13F filings for Q1 2015.